Vanguard Group Inc Beyond Spring Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.13 - $2.66 $131,943 - $310,592	-116,764 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.68 - $5.01 $6,436 - $19,193	3,831 Added 3.39%	116,764 $257,000
Q4 2021 Feb 14, 2022	SELL	$4.02 - $16.84 $24,232 - $101,511	-6,028 Reduced 5.07%	112,933 $511,000
Q3 2021 Nov 12, 2021	BUY	$9.26 - $31.31 $97,174 - $328,567	10,494 Added 9.67%	118,961 $1.88 Million
Q2 2021 Aug 13, 2021	BUY	$9.37 - $12.12 $1.02 Million - $1.31 Million	108,467 New	108,467 $1.13 Million

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.